Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS): a prospective, randomised, open-label implementation studyDominique van Mil, Ron T. Gansevoort, Lyanne M. Kieneker et al.|The Lancet|2023Cited by 72
Screening for chronic kidney disease: change of perspective and novel developmentsDominique van Mil, Ron T. Gansevoort, Lyanne M. Kieneker et al.|Current Opinion in Nephrology & Hypertension|2024Cited by 35
Cost-effectiveness of home-based screening of the general population for albuminuria to prevent progression of cardiovascular and kidney diseaseXavier Pouwels, Hendrik Koffijberg, Dominique van Mil et al.|EClinicalMedicine|2024Cited by 34
Cost-effectiveness of screening for chronic kidney disease: existing evidence and knowledge gapsDominique van Mil, Ron T. Gansevoort, Xavier Pouwels et al.|Clinical Kidney Journal|2023Cited by 19
Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease—A practical update for cliniciansJelle M. Beernink, Ron T. Gansevoort, Dominique van Mil et al.|Diabetes Obesity and Metabolism|2025Cited by 19